Powering Progress Across Global Healthcare Ecosystems

We are the industry leader in the CDMO sector and offer improved quality outsourced development and manufacture of pharmaceuticals to leading generic pharma firms, branded pharma firms, and biotech firms. The areas of our focus are drug formulation, analytical testing, manufacture, and packaging, and helping clients have products reach the marketplace on time and regulatory compliance.

We have open partnership terms and P2P (Product-to-Product) and Loan License business models to meet our customers. We offer strategic, long-term value with focus on time-to-market, quality, and innovation in development, commercialization, product enhancement, and lifecycle management (LCM).

Since it started its export operation in 2015 with a CDDA (Sri Lanka FDA authority) license, Synokem Pharmaceutical Limited has been developing its global reach in various continents in the past seven years. We have expanded into other markets by securing international regulatory approvals and passing various country-specific audits successfully. We continue to focus on conducting new stringent regulatory authority (SRA) audits with an objective to enter regulated markets.

Synokem Pharmaceuticals' Institutional Division is a business of supplying good quality drugs to large government and semi-governmental departments, public sector hospitals, and state procurement organizations all over India.

The Branded Rx Division (Ethical Division) is the maiden business division of the company. It has been engaged in ethical promotion of prescription medicines to the medical community throughout India since 1983.